COVID-19 impact on the sales of the biotechnology industry in Spain 2020
More than 45 percent of of the biotechnology companies surveyed by the Spanish Bioindustry Association (ASEBIO) stated that COVID-19 had no impact on their sales revenue. Around 14 percent of the firms reported that they were seriously affected, while almost 11 percent percent stated that COVID-19 had a positive impact on their sales revenue.